• About Us
    • Company
    • Chairman's Message
    • Team Profile
    • Our History
    • Corporate Culture
    • Corporate Honors
  • Technology
    • Research and Development
    • Innovation Platform
    • Innovative Drugs
    • Research and Development Pipeline
  • Products
    • Digestive System
    • Cardiovascular System
    • Endocrine System
    • Nervous System
    • Inflammation
    • Respiratory System
  • News
    • Company News
    • Media Coverage
  • Investor Relations
    • Announcements and Circulars
    • Financial Reports
    • Prospectus
    • Corporate Governance
    • Contact IR
  • Careers
    • Talent Development
    • Recruitment Position
  • Contact Us
    • Contact Us
    • Product Consultation
  • 简 繁 EN
  • 中文
  • 繁体
  • EN
  • About Us
  • Company
  • Chairman's Message
  • Team Profile
  • Our History
  • Corporate Culture
  • Corporate Honors
  • Technology
  • Research and Development
  • Innovation Platform
  • Innovative Drugs
  • Research and Development Pipeline
  • Products
  • Digestive System
  • Cardiovascular System
  • Endocrine System
  • Nervous System
  • Inflammation
  • Respiratory System
  • News
  • Company News
  • Media Coverage
  • Investor Relations
  • Announcements and Circulars
  • Financial Reports
  • Prospectus
  • Corporate Governance
  • Contact IR
  • Careers
  • Talent Development
  • Recruitment Position
  • Contact Us
  • Contact Us
  • Product Consultation
Investor Relations
  1. Home
  2. Investor Relations
  3. Announcements and Circulars
Announcements and Circulars Financial Reports Prospectus Corporate Governance Contact IR
  • 2026
  • 2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
2026-01-07
Download
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
2025-12-02
Download
CHANGE OF JOINT COMPANY SECRETARY, AUTHORIZED REPRESENTATIVES AND PROCESS AGENT AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
2025-11-21
Download
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
2025-11-05
Download
ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS
2025-10-20
Download
[Other - Miscellaneous]DELAY IN LISTING TIMETABLE
2025-10-16
Download
About Us
Technology
Products
News
Investor Relations
Careers
Contact Us

Fujian Haixi Pharmaceutical Co., Ltd. Fujian ICP Record No. 12015727 Internet Drug Information Service Qualification Certificate No.: (Min)-Non-operating-2023-0063

Some texts and images on this website are sourced from the Internet for sharing and learning purposes only. If any content infringes your rights and interests, please notify us promptly, and we will handle or remove the relevant materials without delay.